The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Novartis has a third FDA-approved indication ... a green light in ultra-rare kidney disease C3 glomerulopathy (C3G). Fabhalta (iptacopan) is the first treatment approved for C3G, which mostly ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease ... which was approved to treat CKD patients earlier this year by the FDA, adding to an ...

Ozempic is becoming popular among diabetics and people who want to lose weight. But it has a few side effects, including ...

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

The FDA approved three natural food dyes this week amid its transition away from petroleum-based dyes in the food supply. The colors "will expand the palette of available colors from natural ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

The popularity of weight loss drugs has caused a shortage in recent years, but how effective are they at helping with food ...

The FDA approved three natural food dyes, following petitions from Sensient, Innophos and Fermentalg, as the agency works to remove all petroleum-based food dyes from the food system by the end of ...